ALBT - Company ID 0001630212
The table below shows Avalon GloboCare Corp.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | $1.33M | $1.26M | $1.20M | $1.39M | $1.38M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | $272.73K | $414.52K | $390.20K |
| R&D | - | - | $109.62K | $731.33K | $1.03M | $883.86K |
| SG&A |
Avalon GloboCare Corp. reported annual revenue of $1.33M for fiscal year 2024. That is up 6.2% from $1.26M in fiscal 2023. Over the 9 fiscal years shown, annual revenue grew from $616.45K (FY 2016) to $1.33M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| - |
| Operating income | -$7.59M | -$4.84M | -$15.75M | -$8.79M | -$8.83M | -$12.45M |
| Income tax | - | - | - | - | - | - |
| Net income | -$18.26M | -$7.90M | -$16.71M | -$11.93M | -$9.09M | -$12.68M |
| EPS (diluted) | -$5.64 | -$8.44 | -$23.80 | -$1.28 | -$1.07 | - |